COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 481

Article download: 147

Indian Journal of Clinical Anatomy and Physiology


To analyze the variations in cost of Anti-glaucoma eye preparations available in Indian market


Full Text PDF Share on Facebook Share on Twitter


Author Details : Adil Ali Shakur, Akash Chandra, Asish Kumar Biswas, Manish Kumar, Lalit Mohan

Volume : 3, Issue : 3, Year : 2018

Article Page : 98-100


Suggest article by email


Abstract

Aim: To analyze the percentage cost variations among different brands of the commonly prescribed anti–glaucoma drugs.
Material and Methods: The maximum and minimum price of each brand of the drug in INR was noted by using CIMS January to April 2018 edition Drug Today April to June 2018 Vol-1. The cost ratio and the percentage cost variation for individual drug brands was calculated. The cost of each eye drop was calculated. At last the cost ratio and percentage cost variation of various brands was compared.
Results:Percentage variation in cost for anti-glaucoma eye preparations marketed in India was found to be Eye drop Timolol maleate (0.5%) of 5ml:263.63, Eye drop Dorzolamide (2%) of 5ml:9.77, Eye drop Pilocarpine (2%) of 5ml:160.40, Eye drop Betaxolol (0.5%) of 5ml:56.54, Eye drop Latanoprost(50mcg/ml) of 2.5ml:135.88, Eye drop Brimonidine tartarate (0.15%) of 5ml:183.9, Eye drop Levobunolol (5mg/ml) of 5ml:32.38,
Conclusion:Glaucoma is the most common ocular disease and eye drops are to be prescribed for prolonged period. If a costly brand is prescribed, the patients have to pay more money unnecessarily for their treatment. The clinicians prescribing these drugs should be aware of these variations in cost to reduce the cost of drug therapy.

Keywords: Glaucoma, Percentage cost variation, Cost ratio.

Doi : 10.18231/2456-9542.2018.0023

How to cite : Shakur A A, Chandra A, Biswas A K, Kumar M, Mohan L, To analyze the variations in cost of Anti-glaucoma eye preparations available in Indian market. Indian J Clin Anat Physiol 2018;3(3):98-100

Copyright © 2018 by author(s) and Indian J Clin Anat Physiol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)